SAFC, a custom manufacturing and services business unit of Sigma-Aldrich, has expanded its portfolio of PharmaGrade raw materials which are used for manufacturing biopharmaceuticals. The portfolio, in addition to 25 new raw materials, ...
Tags: raw materials, biopharmaceuticals, SAFC
RegeneRx Biopharmaceuticals has received an issued patent in Mexico and allowances of three additional patent applications in Mexico and Israel, related to Thymosin beta 4 (Tβ4). The patents are set to expire 2024-2026, the ...
Kaneka has unveiled KANEKA KanCapA, a new protein A chromatography resin to purify therapeutic antibodies. Protein A chromatography resin is widely used to produce antibodies due to its high affinity and excellent selectivity for ...
Navidea Biopharmaceuticals has reported a net loss attributable to common stockholders of $9.12m, or $0.09 per share, for the third quarter ended 30 September 2012 compared to a net income attributable to common stockholders of $19.81m, or ...
Tags: Navidea Biopharmaceuticals, common stockholders, radiopharmaceutical
Cellon, a provider of products and services to the vaccine production and bioprocessing industries, has introduced PharmaTainer sterile single-use containers for storage, freezing, and manipulation of biological solutions. The ...
Tags: Biological Solution, biological product, Single-Use Container
Keryx Biopharmaceuticals has reported a net loss of $5.47m, or $0.08 per share, for the third quarter ended 30 September 2012 compared to a net loss of $10.25m, or $0.15 per share, for the third quarter ended 30 September 2011. Operating ...
Tags: Net Loss, Biopharmaceuticals, top-line data
Daiichi Sankyo has signed an exclusive agreement with Coherus BioSciences to develop and commercialize biosimilar candidates in certain Asian countries including Japan. The collaboration will focus on the development, manufacturing and ...
Tags: Daiichi Sankyo, Coherus BioSciences, biosimilar candidates
XTL Biopharmaceuticals has acquired 4,620,356 shares of Proteologics from Teva Pharmaceutical for nearly NIS6.5m($1.6m). The company has purchased single share at an amount of NIS1.405($0.36). The acquired shares represent all the ...
Tags: XTL Biopharmaceuticals, shares, drugs, multiple myeloma, schizophrenia
SK Biopharmaceuticals has signed a licensing agreement with Hanmi Pharmacutical for diazepam nasal spray (DZNS) technology. Under the terms of the agreement, Hanmi acquired regional marketing rights for Korea and China and will make an ...
Tags: Hanmi for Dzns Technology, Medicine, Pharmacutical Hanmi
SK Biopharmaceuticals, a South Korean pharmaceutical company, has received orphan drug designation status for carisbamate for the management of patients with infantile spasms (IS). Carisbamate has previously been shown to have ...
Biocon has invested in new integrated research and development centre, Biocon Research Center (BRC), in South-East Asia to conduct research on biologics that will deal with unmet medical needs. The 200,000ft2 will accommodate the ...
Tags: Biocon, invested, BRC, research on biologics, South-East Asia
The market for equipment, services and chemicals used in treating and controlling liquids, indoor air, stack gases and process fluids will grow from $381 billion in 2012 to $403 billion in 2017. This is the latest forecast in the McIlvaine ...
Tags: News Update, Industry Trends, Gas Treatment